Website & contact details
- Group website
- The site of this company’s group or brand.
Meridian Bioscience International Limited
- Incorporated
- 1 April 2014 (12 years)
- Industry
- Activities of head offices (70100)
- Directors
- Emerson Moser
- Owned by
- Meridian Bioscience, Inc
- Accounts type
- Full
- Region
- Greater London
- Address
- 16 The Edge Business CentreHumber RoadLondonNW2 6EW
Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 15 April 2027
- Last conf. stmt
- 1 April 2026
Charges
- Total
- 4
- Outstanding
- 4
- Part satisfied
- 0
- Satisfied
- 0
Officers 2 active
Officer details are public data from the Companies House register.
Moser, Emerson
Director · Appointed 1 July 2023
American
Born June 1976 (50)
American
Born March 1979 (47)
Officer history (9 former)
1 July 2023
Appointed Moser, Emerson as Director
30 June 2023
31 January 2023
23 March 2022
23 March 2022
23 March 2022
23 March 2022
Resigned Parker, Alan Michael as Secretary
31 December 2021
Resigned Baldasare, Bryan as Director
21 June 2019
25 January 2019
13 December 2018
Resigned Lueke, Melissa Ann as Director
12 June 2018
23 January 2018
23 January 2018
20 January 2015
20 January 2015
Appointed Lueke, Melissa Ann as Director
20 January 2015
1 April 2014
Appointed Baldasare, Bryan as Director
1 April 2014
Appointed Parker, Alan Michael as Secretary
1 April 2014
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Meridian Bioscience, Inc
Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Us Publicly Traded Compnay
Holdings 2
Companies where Meridian Bioscience International Limited is registered as a person with significant control
Owns 75–100% of shares
Active
Owns 75–100% of shares
Active
Financials
Figures from 2024 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £70,628,463
- Cash
- £696,654
- Turnover
- £1,461,182
- Profit Before Tax
- £6,077,996
- Employees
- 8
- Current Ratio
- 5.6x
- Return on Equity
- 9%
Trend
Turnover
Balance sheet detail
| 2024 | 2023 | 2021 | |
|---|---|---|---|
| Fixed Assets | £69,622,103 | £69,623,083 | |
| Current Assets | £1,225,916 | £2,105,260 | £3,153,788 |
| Debtors | £345,779 | ||
| Cash | £696,654 | £1,444,718 | £2,808,009 |
| Creditors (< 1 year) | £219,556 | £172,058 | £237,083 |
| Net Current Assets | £1,006,360 | £1,933,202 | £2,916,705 |
| Net Assets | £70,628,463 | £71,555,305 | £72,539,788 |
| Shareholder Funds | £70,628,463 | £71,555,305 | £72,539,788 |
| Turnover | £1,461,182 | £1,740,478 | £1,493,077 |
| Gross Profit | £1,493,077 | ||
| Admin Expenses | £1,449,542 | £1,892,530 | £1,420,779 |
| Staff Costs | £1,110,481 | £1,271,033 | |
| Operating Profit | £11,640 | (£152,052) | £44,460,988 |
| Profit Before Tax | £6,077,996 | £22,778,658 | £44,473,447 |
| Tax | £4,838 | £138 | £16,104 |
| Profit for Period | £6,073,158 | £22,778,520 | £44,457,343 |
Filings 61
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 23 September 2026 | Full accounts | 31 December 2025 | ||
| 27 April 2026 | Confirmation statement with no updates | 1 April 2026 | ||
| 24 April 2026 | Replacement filing for the appointment of a director | |||
| 15 September 2025 | Full accounts | 31 December 2024 | ||
| 6 May 2025 | Confirmation statement with no updates | 1 April 2025 |
Some other companies at this address
Other companies in this industry
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →